Publications by authors named "Craig Moskowitz"

Claim this Profile
U
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation: The ULTRA-HFIB Pilot.
William Whang, Devi Nair, Rahul Bhardwaj, Marc Lahiri, Dinesh Sharma, Craig Moskowitz

JACC Clin Electrophysiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma.
Juan Pablo Alderuccio, Russ A Kuker, Eduardo Edelman Saul, Michele D Stanchina, Mark K Polar, Craig H Moskowitz

Am J Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.
Efrat Luttwak, Edith Tama Robin, Esther Drill, Alexander Boardman, Philip Caron, Craig H Moskowitz, Alison J Moskowitz

Leuk Lymphoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial.
Russ A Kuker, Juan P Alderuccio, Sunwoo Han, Mark K Polar, Tracy E Crane, Craig H Moskowitz

JCO Clin Cancer Inform· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procainamide-facilitated induction of Purkinje premature ventricular contractions in a patient with idiopathic ventricular fibrillation.
Mai Badr, Sindhuja Palle, Craig Moskowitz, Aneesh Tolat

HeartRhythm Case Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial.
Juan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, Russ A Kuker, Georgios Pongas, Craig H Moskowitz

Lancet Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Alex F Herrera, Michael LeBlanc, Sharon M Castellino, Hongli Li, Sarah C Rutherford, Craig Moskowitz

N Engl J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Alison J Moskowitz, Craig H Moskowitz

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis.
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Zinzani, Ann S LaCasce, Craig H Moskowitz, Alison J Moskowitz

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP.
Kurt S Bantilan, Alexandra N Smith, Matthew J Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, Craig H Moskowitz

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Alison J Moskowitz, Craig H Moskowitz

Haematologica· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial.
Juan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom, Craig H Moskowitz

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma.
Parastoo B Dahi, Sheila Kenny, Jessica Flynn, Sean M Devlin, Josel D Ruiz, Craig H Moskowitz

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma.
Julia Driessen, Gerben J C Zwezerijnen, Heiko Schöder, Marie José Kersten, Alison J Moskowitz, Craig H Moskowitz

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
Philippe Armand, Pier Luigi Zinzani, Hun Ju Lee, Nathalie A Johnson, Pauline Brice, Craig H Moskowitz

Blood· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative PET-based biomarkers in lymphoma: getting ready for primetime.
Juan Pablo Alderuccio, Russ A Kuker, Fei Yang, Craig H Moskowitz

Nat Rev Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Unmet Supportive Care Needs and Emergency Department Visits and Hospitalizations in Ambulatory Oncology.
Frank J Penedo, Akina Natori, Sara E Fleszar-Pavlovic, Vandana D Sookdeo, Jessica MacIntyre, Craig Moskowitz

JAMA Netw Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.
Francesco Maura, Bachisio Ziccheddu, Jenny Z Xiang, Bhavneet Bhinder, Joel Rosiene, Craig H Moskowitz

Blood Cancer Discov· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen.
Laure Michaud, Kurt Bantilan, Audrey Mauguen, Craig H Moskowitz, Andrew D Zelenetz

J Nucl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with or mutations: an open label phase II study.
David Qualls, Ariela Noy, David Straus, Matthew Matasar, Craig Moskowitz

Leuk Lymphoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting.
Serena Zheng, Kanika Gupta, Piyush Goyal, Reiko Nakajima, Laure Michaud, Alison J Moskowitz, Craig H Moskowitz

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study.
John Kuruvilla, Philippe Armand, Mehdi Hamadani, Justin Kline, Craig H Moskowitz

Leuk Lymphoma· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design.
Anita Kumar, Carla Casulo, Erel Joffe, Craig Moskowitz, John Gerecitano, Alison Moskowitz

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap for clinical trial design in marginal zone lymphoma.
Juan Pablo Alderuccio, Thomas Habermann, Russ Kuker, Craig H Moskowitz, Andrew D Zelenetz

Am J Hematol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma.
Russ A Kuker, David Lehmkuhl, Deukwoo Kwon, Weizhao Zhao, Izidore S Lossos, Craig H Moskowitz

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis